JP2008514722A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008514722A5 JP2008514722A5 JP2007534782A JP2007534782A JP2008514722A5 JP 2008514722 A5 JP2008514722 A5 JP 2008514722A5 JP 2007534782 A JP2007534782 A JP 2007534782A JP 2007534782 A JP2007534782 A JP 2007534782A JP 2008514722 A5 JP2008514722 A5 JP 2008514722A5
- Authority
- JP
- Japan
- Prior art keywords
- atorvastatin calcium
- amorphous atorvastatin
- amorphous
- drying
- container
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61457804P | 2004-09-30 | 2004-09-30 | |
| IN715CH2005 | 2005-06-10 | ||
| PCT/US2005/035094 WO2006039441A2 (en) | 2004-09-30 | 2005-09-29 | Amorphous atorvastatin calcium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008514722A JP2008514722A (ja) | 2008-05-08 |
| JP2008514722A5 true JP2008514722A5 (https=) | 2009-03-12 |
Family
ID=36143063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007534782A Pending JP2008514722A (ja) | 2004-09-30 | 2005-09-29 | 非結晶性アトルバスタチンカルシウム |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20080009540A1 (https=) |
| EP (1) | EP1793815A4 (https=) |
| JP (1) | JP2008514722A (https=) |
| KR (1) | KR20070106680A (https=) |
| CA (1) | CA2582449A1 (https=) |
| TW (1) | TW200618795A (https=) |
| WO (1) | WO2006039441A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009013633A2 (en) * | 2007-07-20 | 2009-01-29 | Actavis Group Ptc Ehf | Amorphous coprecipitates of atorvastatin pharmaceutically acceptable salts |
| EP2075246A1 (en) * | 2007-12-27 | 2009-07-01 | M. J. Institute of Research | A process for preparation of amorphous form of atorvastatin hemi-calcium salt |
| WO2009090544A2 (en) * | 2008-01-16 | 2009-07-23 | Matrix Laboratories Limited | Process for producing amorphous atorvastatin calcium |
| WO2010066687A2 (en) * | 2008-12-11 | 2010-06-17 | Dsm Ip Assets B.V. | Stabalized statin-comprising compositions |
| HUP1000299A2 (hu) | 2010-06-08 | 2012-02-28 | Nanoform Cardiovascular Therapeutics Ltd | Nanostrukturált Atorvastatint, gyógyszerészetileg elfogadott sóit és kokristályait tartalmazó készítmény és eljárás elõállításukra |
| RU2014124118A (ru) | 2011-11-15 | 2015-12-27 | Др. Редди'С Лабораторис Лтд. | Фармацевтические препараты, включающие аторвастатин и глимепирид |
| MX2015003312A (es) * | 2012-09-17 | 2015-07-14 | Dsm Sinochem Pharm Bv | Proceso para producir intermedios de atorvastatina. |
| WO2017042995A1 (ja) * | 2015-09-07 | 2017-03-16 | パナソニックＩｐマネジメント株式会社 | 車載用ステレオカメラ装置、およびその補正方法 |
| CN109280024A (zh) * | 2018-10-09 | 2019-01-29 | 河南师范大学 | 一种高纯度阿托伐他汀叔丁酯的制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ210840A (en) * | 1984-01-18 | 1987-05-29 | Johnson & Johnson Baby Prod | Composition comprising synergistic combination of miconazole nitrate and zinc oxide |
| HRP960312B1 (en) * | 1995-07-17 | 2001-10-31 | Warner Lambert Co | NOVEL PROCESS FOR THE PRODUCTION OF AMORPHOUS /R-(R*, R*)/-2-(4-FLUOROPHENYL)-"beta", "delta"-DIHYDROXY-5-PHENYL-4-/(PHENYLAMINO)CARBONYL/-1H-PYRROLE -1-HEPTANOIC ACID CALCIUM SALT (2 : 1) |
| US6673374B2 (en) * | 1998-07-31 | 2004-01-06 | Howard Murad | Pharmaceutical compositions and methods for managing skin conditions |
| JP2002035579A (ja) * | 2000-07-24 | 2002-02-05 | Mitsubishi Gas Chem Co Inc | 水蒸気を吸収する脱酸素剤組成物 |
| IL156055A0 (en) * | 2000-11-30 | 2003-12-23 | Teva Pharma | Novel crystal forms of atorvastatin hemi calcium and processes for their preparation as well as novel processes for preparing other forms |
| US7501450B2 (en) * | 2000-11-30 | 2009-03-10 | Teva Pharaceutical Industries Ltd. | Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| IN190564B (https=) | 2001-04-11 | 2003-08-09 | Cadila Heathcare Ltd | |
| WO2003068191A1 (en) * | 2002-02-14 | 2003-08-21 | Ranbaxy Laboratories Limited | Formulations of atorvastatin stabilized with alkali metal additions |
| HRP20040767A2 (en) * | 2002-02-19 | 2004-12-31 | Teva Pharma | Desolvating solvates of atorvastatin hemi-calcium |
| SI21302A (sl) * | 2002-10-11 | 2004-04-30 | LEK farmacevtska dru�ba d.d. | Stabiliziran farmacevtski izdelek z amorfno aktivno učinkovino |
| US7655692B2 (en) * | 2003-06-12 | 2010-02-02 | Pfizer Inc. | Process for forming amorphous atorvastatin |
| TW200513199A (en) * | 2003-08-12 | 2005-04-16 | Mitsubishi Gas Chemical Co | Oxygen absorber composition, oxygen absorber packaging and oxygen absorption method |
| SK50782006A3 (sk) * | 2004-02-26 | 2007-03-01 | Zentiva, A. S. | Amorfné formy risedronátu monosodného |
| WO2005090301A1 (en) * | 2004-03-17 | 2005-09-29 | Ranbaxy Laboratories Limited | Crystalline form of atorvastatin hemi calcium |
| AU2004317336A1 (en) * | 2004-03-19 | 2005-09-29 | V.B. Medicare Private Limited | An improved process for producing chlorinated sucrose |
-
2005
- 2005-09-29 EP EP05803604A patent/EP1793815A4/en not_active Withdrawn
- 2005-09-29 JP JP2007534782A patent/JP2008514722A/ja active Pending
- 2005-09-29 CA CA002582449A patent/CA2582449A1/en not_active Abandoned
- 2005-09-29 WO PCT/US2005/035094 patent/WO2006039441A2/en not_active Ceased
- 2005-09-29 KR KR1020077007918A patent/KR20070106680A/ko not_active Ceased
- 2005-09-29 US US11/576,396 patent/US20080009540A1/en not_active Abandoned
- 2005-09-30 TW TW094134218A patent/TW200618795A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100643971B1 (ko) | 건조 장치 및 그의 제조 방법 | |
| EP0943674B1 (en) | Oxygen absorbent composition | |
| JP2008514722A5 (https=) | ||
| JPH08325141A (ja) | 乾燥剤を含有する経皮薬物供給具 | |
| WO2014195966A2 (en) | Amorphous form of canagliflozin and process for preparing thereof | |
| CN108271991A (zh) | 一种具备吸湿功能的食品用脱氧剂及其制备方法 | |
| AR047619A1 (es) | Producto farmaceutico estabilizado | |
| JP2008514722A (ja) | 非結晶性アトルバスタチンカルシウム | |
| CN102989412A (zh) | 一种高效除湿剂 | |
| TW200400065A (en) | Drug delivery assembly | |
| RU2419436C2 (ru) | Стабилизация тестостерона в устройствах чрескожного действия | |
| WO2001093859A1 (en) | Stable pharmaceutical product and formulation | |
| JP2002336693A (ja) | 酸素吸収剤組成物 | |
| US20070066578A1 (en) | 5-Aminosalicylic acid solid preparation improved in discoloration and method of storing the same | |
| JP3134291B2 (ja) | 酸素吸収用組成物 | |
| CN100490941C (zh) | 一种干燥剂在活菌制剂干燥中的应用 | |
| CN1079766A (zh) | 一种高效防潮、防霉剂 | |
| JPS62220178A (ja) | 食品等の保存剤 | |
| JP2668888B2 (ja) | 酸素吸収剤 | |
| CN107876004A (zh) | 一种除湿剂 | |
| JPS6214940A (ja) | 脱酸素剤の製造法 | |
| JP2000085851A (ja) | 脱酸素樹脂組成物、脱酸素包装材料及びこれらを用いる脱酸素容器の乾燥保存方法 | |
| JPS609683B2 (ja) | 安定な農薬組成物の製造方法 | |
| JP2002138244A (ja) | 包装材料用塗料およびこれからなる塗膜を有する包装材料 | |
| JPS58209934A (ja) | 食品の鮮度を保持する包装方法および包装材料 |